Clinical And Genetic Study of The Sptlc1 Gene Mutation in Patients With Heridetary Sensory Neuropahty Type 1
DOI:
https://doi.org/10.31436/imjm.v8i1.767Abstract
Introduction: Hereditary sensory neuropathy type 1 (HSN1) is the most common hereditary disorder of peripheral sensory neurons. Materials and methods: This study was carried out on 15 patients with hereditary sensory neuropathy type-1 and 10 healthy individuals as a control group. Detailed family history and thorough clinical and neurological examination were performed to all patients. Nerve conduction velocity of ulnar and lateral popliteal nerves (motor and sensory) as well as audiograms was carried out for all members of the studied groups. The laboratory study included the determination of serum C-reactive protein (CRP) and serum nucleasomes as well as molecular detection of the serine palmitoytransferase (SPTLC-1) gene mutations for all studied groups. Results: There was predominance in male who developed more sever clinical manifestations than females. The disease onset was in the second and third decades of life. Patients with HSN 1 manifested reduced conduction velocity in both motor and sensory fibers of the lateral popliteal nerve (p< 0.01) however the ulnar nerve was spared (p = 0.61). Audiometry revealed bilateral partial nerve deafness in 3 cases and complete deafness in one case. Serum CRP and nucleosomes were significantly elevated in all patients as compared to the control group (p < 0.01). The genetic study revealed mutations of the SPTLC1 in all studied patients compared to the control group. Point mutation C133W was observed in younger patients having severe clinical manifestations with prominent leg ulceration, while the point mutation C133Y was observed in the older patients complaining of hearing loss. The mutation V144D was found in patients with mild clinical presentation having minimal ulceration and no hearing abnormalities. Conclusion: The SPTLC1 gene mutations play an important role in the pathogenesis and variability in clinical presentation of HSN1 disease.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.